The few studies addressing the effect of POMs in melanoma, with most of them using B16 murine melanoma cells, reported a decrease in cell viability and antitumor activity [50,51], as well as impaired cellular tyrosinase activity and melanin formation [52]. This evidence concerns the gene TYR and melanoma.